Fang Sui
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 4
Fang Sui
32 papers receiving 656 citations
Peers
Comparison fields: 5 of 94
- Cancer Research 142
- Molecular Biology 394
- Oncology 137
- Biomaterials 63
- Pathology and Forensic Medicine 69
Countries citing papers authored by Fang Sui
This map shows the geographic impact of Fang Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Sui more than expected).
Fields of papers citing papers by Fang Sui
This network shows the impact of papers produced by Fang Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Sui. The network helps show where Fang Sui may publish in the future.
Co-authors
The 25 scholars most cited alongside Fang Sui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 3 | |
| 12 | 2018 | 10 | |
| 13 | 2018 | 46 | |
| 14 | 2017 | 18 | |
| 15 | 2017 | 33 | |
| 16 | 2016 | 16 | |
| 17 | Decreased 5-Hydroxymethylcytosine (5-hmC) predicts poor prognosis in early-stage laryngeal squamous cell carcinoma. | 2016 | 15 |
| 18 | 2014 | 4 | |
| 19 | 2013 | 10 | |
| 20 | 2012 | 10 |
About Fang Sui
Fang Sui is a scholar working on Cancer Research, Biological Psychiatry, Endocrinology, Molecular Biology and Oncology, having authored 33 papers that have together received 663 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (4 papers), Cancer-related gene regulation (4 papers), Epigenetics and DNA Methylation (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), Ubiquitin and proteasome pathways (3 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Cancer Research (142 citations), Molecular Biology (394 citations), Oncology (137 citations), Biomaterials (63 citations) and Pathology and Forensic Medicine (69 citations). Fang Sui has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Peng Hou, Meiju Ji, Qi Yang, Demao Yao, Xi Su, Jingjing Ma, Yiping Qu, Zhen Shen, Jun Pu and Bingyin Shi. Their work appears in journals such as Oncotarget, BMC Cancer, European Journal of Medicinal Chemistry, Chemistry of Materials and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.